SCHEMBL22247213

SCHEMBL22247213

O=C(O)CC1OC(CCO)C(O)C(n2cc(-c3cc(F)c(F)c(F)c3)nn2)C1O

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 20/20 0.61
▸ LGALS1 P09382 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22247034 0.92 LGALS3 (0.72) LGALS3LGALS1
SCHEMBL22247158 0.82 LGALS3 (0.73) LGALS3LGALS1
SCHEMBL22247026 0.81 LGALS3 (0.66) LGALS3LGALS1
SCHEMBL22982173 0.80 LGALS3 (0.71) LGALS3LGALS1
SCHEMBL22247029 0.78 LGALS3 (0.56) LGALS3LGALS1
SCHEMBL23374337 0.78 LGALS3 (0.65) LGALS3
SCHEMBL22247289 0.78 LGALS3 (0.73) LGALS3LGALS1
SCHEMBL23374316 0.78 LGALS3 (0.87) LGALS3LGALS1
SCHEMBL23374332 0.77 LGALS3 (0.88) LGALS3
SCHEMBL23374351 0.77 LGALS3 (0.89) LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150263-A1 SELECTIN OR GALECTIN ANTAGONISTS FOR TREATING CYTOKINE RELEASE SYNDROME AND CRS-INDUCED NEUROTOXICITY MAGNANI JOHN L (US) 2020-07-23 — — WO disclosed
Send feedback